Postexposure Prophylaxis After Sexual Assaults: A Prospective Cohort Study

dc.creatorGarcia M.T.
dc.creatorFigueiredo R.M.
dc.creatorMoretti M.L.
dc.creatorResende M.R.
dc.creatorBedoni A.J.
dc.creatorPapaiordanou P.M.O.
dc.date2005
dc.date2015-06-26T14:07:02Z
dc.date2015-11-26T15:41:22Z
dc.date2015-06-26T14:07:02Z
dc.date2015-11-26T15:41:22Z
dc.date.accessioned2018-03-28T22:49:52Z
dc.date.available2018-03-28T22:49:52Z
dc.identifier
dc.identifierSexually Transmitted Diseases. , v. 32, n. 4, p. 214 - 219, 2005.
dc.identifier1485717
dc.identifier10.1097/01.olq.0000149785.48574.3e
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-15744399834&partnerID=40&md5=aa8b3006c49deb60554aa53aee2f8ab4
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/93266
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/93266
dc.identifier2-s2.0-15744399834
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1264603
dc.descriptionObjective: The objective of this study was to evaluate HIV postexposure prophylaxis (PEP) protocol in rape victims. Study: The victims were assigned to 1 of 3 categories, according to the severity of exposure (I-low, II-moderate, III-high). HIV PEP was provided to victims in groups II (Zdv + 3TC) and III (Zdv + 3TC + PI) until 72 hours after exposure. The follow-up was 6 months. Results: From May 1997 to October 2001, 347 victims were attended. PEP was offered to 278 victims (141 in group II and 137 in group III). Side effects were more common in group III (P <0.01). No seroconversion was diagnosed in the 180 victims that completed the follow-up. Univariate analysis showed that the schooling level, knowledge of the aggressor's HIV status, and the use of PEP were associated with compliance. Conclusions: Triple therapy was associated with side effects, which suggested that drug regimes should be reviewed. The variables related to a high risk of HIV transmission were also significant for compliance. Copyright © 2005, American Sexually Transmitted Diseases Association All rights reserved.
dc.description32
dc.description4
dc.description214
dc.description219
dc.descriptionTsai, C.C., Follis, K.E., Sabo, A., Prevention of SIV infection in macaques by (R)-9-(2- phosphonylmethoxypropyl) adenine (1995) Science, 270, pp. 1197-1199
dc.descriptionSperling, R.S., Shapiro, D.E., Coombs, R.W., Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant (1996) N Engl J Med, 335, pp. 1621-1629
dc.descriptionCardo, D.M., Culver, D.H., Ciessielski, C.A., A case-control study of HIV seroconversion in health care workers after percutaneous exposure (1997) N Engl J Med, 337, pp. 1542-1543
dc.descriptionUpdate. US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for post-exposure prophylaxis (2001) MMWR Morb Mortal Wkly Rep, 50 (RR-11), pp. 1-42
dc.descriptionManagement of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy (1998) MMWR Morb Mortal Wkly Rep, 47 (RR-17), pp. 1-14
dc.descriptionMyles, J.E., Bamberger, J., (2001) Offering HIV Prophylaxis Following Sexual Assault: Recommendations for the State of California, , http://hivinsite.ucsf.edu/pdf/pepassault.pdf
dc.descriptionLaporte, A., Jourdan, N., Bouvet, E., Post-exposure prophylaxis after non-occupational HIV exposure: Impact of recommendations on physicians' experiences and attitudes (2002) AIDS, 16, pp. 397-405
dc.descriptionCohen, M.S., Eron, J.J., Sexual HIV transmission and its prevention HIV Medscape HIV/AIDS Clinical Management Modules, 18. , www.medscape.com/Medscape/HIV/ClinicalMgmt/CM.v18/public/index-CM.v18. html
dc.descriptionKahn, J.O., Martin, J.N., Roland, M.E., Feasibility of post-exposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: The San Francisco PEP study (2001) J Infect Dis, 183, pp. 707-714
dc.descriptionKatz, M., Gerberding, J.L., The care of persons with recent sexual exposure to HIV (1998) Ann Intern Med, 128, pp. 306-312
dc.descriptionFong, C., Post-exposure prophylaxis for HIV infection after sexual assault: When is it indicated? (2001) Emerg Med J, 18, pp. 242-245
dc.descriptionRecommendations for non-occupational postexposure prophylaxis for HIV (2002) Enferm Infecc Microbiol Clin, 20, pp. 391-400
dc.descriptionAlmeda, J., Casabona, J., Simon, B., Proposed Recommendations for the Management of HIV Post-exposure Prophylaxis after Sexual, Injecting Drug or Other Exposures in Europe, , http://www.eurosurveillance.org/em/v09n06/0906-223.asp
dc.description1998 Guidelines for treatment of sexually transmitted diseases (1998) MMWR Morb Mortal Wkly Rep, 47 (RR-1), pp. 1-116
dc.descriptionFleming, D., Wasserheit, J., From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection (1999) Sex Transm Infect, 75, pp. 3-17
dc.descriptionCummins Jr., J., Dezzutti, C.S., Sexual HIV-1 transmission and mucosal defense mechanisms (2000) AIDS Rev, 2, pp. 144-154
dc.descriptionNicolosi, A., Correa Leite, M., Musicco, M., The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: A study of 730 stable couples (1994) Epidemiology, 5, pp. 570-575. , Italian Study Group on HIV Heterosexual Transmission
dc.descriptionPadian, N., Shiboski, S., Glass, S., Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: Results from a ten-year study (1997) Am J Epidemiol, 146, pp. 350-357
dc.descriptionVittinghoff, E., Douglas, J., Judson, F., Per-contact risk of human immunodeficiency virus transmission between male sexual partners (1999) Am J Epidemiol, 150, pp. 306-311
dc.descriptionMastro, T.D., De Vincenzi, I., Probabilities of sexual HIV-1 transmission (1996) AIDS, 10 (SUPPL. A), pp. S75-S82
dc.descriptionTsai, C.-C., Emau, P., Folis, K.E., Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIV mne depends critically on timing of initiation and duration of treatment (1998) J Virol, 72, pp. 4265-4273
dc.descriptionSkov, T., Deddens, J., Petersen, M.R., Prevalence proportion ratios: Estimation and hypothesis testing (1998) Int J Epidemiol, 27, pp. 91-95
dc.descriptionKerr, E., Cottee, C., Chowdhury, R., Jawad, R., Welch, J., The Haven: A pilot referral centre in London for cases of serious sexual assault (2003) Br J Obstet Gynaecol, 110, pp. 267-271
dc.descriptionLimb, S., Kawsar, M., Forster, G.E., HIV post-exposure prophylaxis after sexual assault: The experience of a sexual assault service in london (2002) Int J STD AIDS, 13, pp. 602-605
dc.descriptionMeel, B.L., HIV/AIDS Post-exposure prophylaxis for victims of sexual assault attending Umtata General Hospital, South Africa (2004) Med Gen Med, 6. , XV International AIDS Conference Bangkok, Thailand, 2004 WePeB5847
dc.descriptionVitavasiri, C., Kendornfake, S., Tapanayantra, M., Post exposure prophylaxis of HIV infection in sexually abused children (2004) Med Gen Med, 6. , XV International AIDS Conference Bangkok, Thailand, 2004 TuPeC4747
dc.descriptionRoland, M.E., Martin, J.N., Grant, R.M., Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: Identification and characterization of the source of exposure (2001) J Infect Dis, 184, pp. 1608-1612
dc.descriptionCoombs, R.W., Speck, C.E., Hughes, J.P., Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood (1998) J Infect Dis, 177, pp. 320-330
dc.descriptionHart, C., Lennox, J., Pratt-Palmore, M., Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract (1999) J Infect Dis, 179, pp. 871-882
dc.descriptionCohen, M., Hoffman, I., Royce, R., Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implication for prevention of sexual transmission of HIV-1 (1997) Lancet, 349, pp. 1868-1873. , AIDSCAP Malawi Research Group
dc.descriptionUvin, S., Hogan, J., Caliendo, A., Bacterial vaginosis decreases suppression of female genital tract HIV-1 RNA levels (2000) 7th Conference on Retroviruses and Opportunistic Infections, , San Francisco, CA
dc.descriptionGrosskurth, H., Mosha, F., Todd, J., Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomized controlled trial (1995) Lancet, 346, pp. 530-536
dc.descriptionGostin, L.O., Lazzarini, Z., Alexander, D., HIV testing, counseling, and prophylaxis after sexual assault (1994) JAMA, 271, pp. 1436-1444
dc.descriptionGore, S.M., Bird, A.G., Burns, S., Anonymous HIV surveillance with risk factor elicitation: At Perth (for men) and Cornton Vale (for women) prisons in Scotland (1997) Int J STD AIDS, 8, pp. 166-175
dc.descriptionHolmes, M.M., Resnick, H.S., Frampton, D., Follow-up of sexual assault victims (1998) Am J Obstet Gynecol, 179, pp. 336-342
dc.descriptionSilberman, B., Salmon, D., Questel, F., Anti HIV chemoprophylaxis in the context of accidental sexual exposure by rape (2001) 8th Conference on Retroviruses and Opportunistic Infections, , Chicago
dc.descriptionSoussy, A., Launay, O., Aubert, M., Caudron, J., Post sexual exposure prophylaxis with HAART after sexual assaults (2001) 8th Conference on Retroviruses and Opportunistic Infections, , Chicago
dc.description(1992) Rape in America: A Report to the Nation, p. 287. , Charleston, SC: National Victim Center and Crime Victims Research and Treatment Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina
dc.languageen
dc.publisher
dc.relationSexually Transmitted Diseases
dc.rightsfechado
dc.sourceScopus
dc.titlePostexposure Prophylaxis After Sexual Assaults: A Prospective Cohort Study
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución